212 related articles for article (PubMed ID: 15206528)
1. Hypotheses and type I error in active-control noninferiority trials.
Chen G; Wang YC; Chi GY
J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
[TBL] [Abstract][Full Text] [Related]
2. Choice of delta noninferiority margin and dependency of the noninferiority trials.
Tsong Y; Zhang J; Levenson M
J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
[TBL] [Abstract][Full Text] [Related]
3. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
Hung HM; Wang SJ; O'Neill R
J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
Tsong Y; Zhang J
J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
[TBL] [Abstract][Full Text] [Related]
5. Mixed noninferiority margin and statistical tests in active controlled trials.
Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
[TBL] [Abstract][Full Text] [Related]
6. The adjustment of the type I error rate in noninferiority trials with λ-margin approach: each of two different new drugs is approved with two independent trials with the same active control.
Kang SH; Ryu Y
J Biopharm Stat; 2011 May; 21(3):498-510. PubMed ID: 21442522
[TBL] [Abstract][Full Text] [Related]
7. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
Wang YC; Chen G; Chi GY
J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
[TBL] [Abstract][Full Text] [Related]
8. Noninferiority testing beyond simple two-sample comparison.
Tsong Y; Chen WJ
J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
[TBL] [Abstract][Full Text] [Related]
9. Alternatives for discounting in the analysis of noninferiority trials.
Snapinn SM
J Biopharm Stat; 2004 May; 14(2):263-73. PubMed ID: 15206525
[TBL] [Abstract][Full Text] [Related]
10. Bayesian approach to noninferiority trials for proportions.
Gamalo MA; Wu R; Tiwari RC
J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
[TBL] [Abstract][Full Text] [Related]
11. Statistical issues on objective, design, and analysis of noninferiority active-controlled clinical trial.
Tsong Y; Wang SJ; Hung HM; Cui L
J Biopharm Stat; 2003 Feb; 13(1):29-41. PubMed ID: 12635901
[TBL] [Abstract][Full Text] [Related]
12. A covariate-adjustment regression model approach to noninferiority margin definition.
Nie L; Soon G
Stat Med; 2010 May; 29(10):1107-13. PubMed ID: 20209669
[TBL] [Abstract][Full Text] [Related]
13. Test for the consistency of noninferiority from multiple clinical trials.
Yan X; Wang MC; Su X
J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
[TBL] [Abstract][Full Text] [Related]
14. Reporting of noninferiority trials was incomplete in trial registries.
Dekkers OM; Soonawala D; Vandenbroucke JP; Egger M
J Clin Epidemiol; 2011 Sep; 64(9):1034-8. PubMed ID: 21444195
[TBL] [Abstract][Full Text] [Related]
15. Noninferiority hypotheses and choice of noninferiority margin.
Ng TH
Stat Med; 2008 Nov; 27(26):5392-406. PubMed ID: 18680173
[TBL] [Abstract][Full Text] [Related]
16. A bootstrap-based test for establishing noninferiority in clinical trials.
Chen M; Kianifard F; Dhar SK
J Biopharm Stat; 2006 May; 16(3):357-63. PubMed ID: 16724490
[TBL] [Abstract][Full Text] [Related]
17. Some fundamental issues with non-inferiority testing in active controlled trials.
James Hung HM; Wang SJ; Tsong Y; Lawrence J; O'Neil RT
Stat Med; 2003 Jan; 22(2):213-25. PubMed ID: 12520558
[TBL] [Abstract][Full Text] [Related]
18. Randomization as a basis for inference in noninferiority trials.
Wiens BL
Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness clinical trials in psychiatry: superiority, noninferiority, and the role of active comparators.
Leon AC
J Clin Psychiatry; 2011 Oct; 72(10):1344-9. PubMed ID: 21367350
[TBL] [Abstract][Full Text] [Related]
20. Multiple testing of noninferiority hypotheses in active controlled trials.
Hung HM; Wang SJ
J Biopharm Stat; 2004 May; 14(2):327-35. PubMed ID: 15206530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]